Skip to main content
    O

    OrganiGram Holdings Inc (OGI)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $0.72
    -0.11 (-12.71%)

    Market Cap: $116.93M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    OrganiGram Holdings Inc (OGI) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to OrganiGram Holdings are Organogenesis Holdings (ORGO), Canopy Growth (CGC) and Cardiol Therapeutics (CRDL). By market cap, OrganiGram Holdings ranks 10th of the 13 companies on this page; Tilray (TLRY) is the largest at $359.12M.

    Peer Comparison

    OGI's ROIC of -1.2% is above the peer median of -21.9%, and its revenue growth of 49.4% is above the median of -9.3%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    OrganiGram Holdings (OGI)$116.93MN/A0.4x28.0%-1.2%49.4%0.00%
    Organogenesis Holdings Inc (ORGO)$105.15MN/A0.3x-38.5%-66.3%-69.9%0.00%
    Canopy Growth Corp (CGC)$252.32MN/AN/A-88.1%N/A22.0%0.00%
    Cardiol Therapeutics Inc Class A (CRDL)$127.69MN/AN/A0.0%N/A0.0%0.00%
    Tilray Inc (TLRY)$359.12MN/A0.3x-17.1%-4.9%22.7%0.00%
    Cumberland Pharmaceuticals Inc (CPIX)$88.16MN/A3.1x148.6%N/A-74.0%28.79%
    BioAge Labs, Inc (BIOA)$255.03MN/A27.9x0.0%N/A-85.5%0.00%
    Anika Therapeutics Inc (ANIK)$179.50M18.7x1.4x-1.4%N/A10.0%0.00%
    Lifecore Biomedical Inc. (LFCR)$243.36MN/AN/A-66.8%N/A-18.6%0.00%
    Akebia Ther (AKBA)$131.67MN/A0.6x-22.6%-38.9%-37.2%0.00%
    Journey Medical Corp (DERM)$122.24MN/A1.5x-7.3%-2.8%7.6%0.00%
    SIGA Technologies Inc (SIGA)$196.88M475.0xN/A1.3%N/A-49.7%0.00%
    InterCure Ltd. (INCR)$49.17MN/AN/A-13.2%N/A23.9%0.00%
    Peer median$155.58M246.9x1.4x-10.3%-21.9%-9.3%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to OrganiGram Holdings, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Drug Manufacturers - Specialty & Generic.

    CompanyAboutPeers
    Organogenesis Holdings Inc (ORGO)
    Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures and markets solutions for the advanced wound care and surgical and sports...
    ORGO competitors
    Canopy Growth Corp (CGC)
    Canopy Growth Corporation is engaged in the production, distribution and sale of cannabis and hemp-based products for recreational and medical purposes...
    CGC competitors
    Cardiol Therapeutics Inc Class A (CRDL)
    Cardiol Therapeutics Inc., a clinical-phase biotechnology company, focuses on the research and development of anti-inflammatory therapies for the treatment...
    CRDL competitors
    Tilray Inc (TLRY)
    Tilray Inc. is dedicated to the research, cultivation, production and distribution of medicinal cannabis and cannabinoids.
    TLRY competitors
    Cumberland Pharmaceuticals Inc (CPIX)
    Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development...
    CPIX competitors
    BioAge Labs, Inc (BIOA)
    BioAmber Inc., an industrial biotechnology company, produces and sells bio-succinic acid to various customers in the chemical market primarily in the United...
    BIOA competitors
    Anika Therapeutics Inc (ANIK)
    Anika Therapeutics, Inc., is a joint preservation company in the United States, Europe, and internationally.
    ANIK competitors
    Lifecore Biomedical Inc. (LFCR)
    Lifecore Biomedical, Inc., is an integrated contract development and manufacturing organization in the United States and internationally.
    LFCR competitors
    Akebia Ther (AKBA)
    Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of kidney therapies for patients with kidney disease.
    AKBA competitors
    Journey Medical Corp (DERM)
    Dermira, Inc., a biopharmaceutical company, develops and markets therapies for patients with dermatological diseases in the United States.
    DERM competitors
    SIGA Technologies Inc (SIGA)
    SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health safety and infectious disease markets in the United States.
    SIGA competitors
    InterCure Ltd. (INCR)
    Syneos Health, Inc., a contract research organization, provides various clinical development services for the medical device and biopharmaceutical industries...

    Frequently Asked Questions About OGI

    Who are OrganiGram Holdings' main competitors?

    The companies most similar to OrganiGram Holdings include Organogenesis Holdings (ORGO), Canopy Growth (CGC), Cardiol Therapeutics (CRDL), Tilray (TLRY) and Cumberland Pharmaceuticals (CPIX), listed from the closest match.

    Who is OrganiGram Holdings' biggest competitor?

    Tilray (TLRY) is the largest of the similar companies at $359.12M; Organogenesis Holdings (ORGO) is the closest match by business profile, size, sector and industry.

    How does OGI stock compare with its competitors?

    OGI's P/S is 0.4x against a peer median of 1.4x; its net margin is 28.0% against a peer median of -10.3%.

    Which of OrganiGram Holdings' competitors pays a higher dividend?

    OrganiGram Holdings pays no dividend. Cumberland Pharmaceuticals (CPIX) has a higher forward dividend yield; Cumberland Pharmaceuticals (CPIX) has the highest at 28.79%.

    Is OrganiGram Holdings bigger than its competitors?

    No. OrganiGram Holdings is 10th by market cap among the 13 companies on this page; the largest is Tilray (TLRY) at $359.12M.